ReviewFrontiers in medicine2026
Multitarget protection by Chinese herbal medicines against sensorineural hearing loss: a focus on oxidative stress, apoptosis, and inflammation.
Review in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Based on the molecular mechanisms of sensorineural hearing loss (SNHL), this study aims to explore the role of traditional Chinese medicine (TCM) in the treatment of SNHL, promote the development of deafness-related research, provide new insights for the formulation and medication of TCM in the treatment of SNHL, and further facilitate the better development of new drugs for clinical application. Methods: Relevant literatures on sensorineural hearing loss (SNHL) and its treatment with traditional Chinese medicine (TCM) were reviewed. The pathogenesis of SNHL and the related research achievements of TCM in treating this disease were sorted out, and the existing research conclusions were analyzed and summarized. Results: Sensorineural hearing loss (SNHL) is a type of hearing impairment mainly caused by damage to cochlear hair cells, spiral neurons, and/or the auditory center, including drug-induced deafness, noise-induced deafness, and age-related deafness. Its molecular mechanisms mainly involve apoptosis, oxidative stress injury, immune inflammation, and metabolic disorders. Due to the irreversibility (non-regeneration) of hair cells and spiral neurons, there is currently no effective treatment for hearing loss caused by such damage. In recent years, the use of traditional Chinese medicine (TCM) to treat hearing disorders by regulating the above-mentioned molecular mechanisms has gradually become a research hotspot, and a large number of studies have confirmed that TCM exhibits significant efficacy in hearing treatment. Conclusion: Traditional Chinese medicine (TCM) can exert a therapeutic effect on hearing by regulating the core molecular mechanisms of SNHL (such as apoptosis and oxidative stress injury) and has significant application potential. The discussion in this article can provide a new direction for the formulation and medication of TCM in the treatment of SNHL, and has positive significance for promoting the development of deafness research and the research and development of new clinical drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.